Vanguard Personalized Indexing Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120K Buy
22,805
+3,898
+21% +$24.9K ﹤0.01% 2025
2026
Q1
$138K Buy
18,907
+1,760
+10% +$15.9K ﹤0.01% 1899
2025
Q4
$165K Buy
17,147
+758
+5% +$7.84K ﹤0.01% 1754
2025
Q3
$200K Buy
16,389
+643
+4% +$6.75K ﹤0.01% 1710
2025
Q2
$126K Sell
15,746
-10,737
-41% -$75.4K ﹤0.01% 1704
2025
Q1
$192K Buy
26,483
+3,866
+17% +$28.1K ﹤0.01% 1529
2024
Q4
$156K Buy
22,617
+8,890
+65% +$61.1K ﹤0.01% 1562
2024
Q3
$101K Sell
13,727
-931
-6% -$8.7K ﹤0.01% 1615
2024
Q2
$154K Buy
14,658
+3,962
+37% +$50.2K ﹤0.01% 1489
2024
Q1
$148K Sell
10,696
-1,003
-9% -$15.7K ﹤0.01% 1485
2023
Q4
$227K Buy
+11,699
New +$216K 0.01% 1354

Other funds holding NUS

Vanguard Personalized Indexing Management's NUS Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Nu Skin (NUS) stake by 21% in Q2 2026, buying an estimated $24.9K and bringing the position to 22,805 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

Vanguard Personalized Indexing Management first reported a position in NUS in Q4 2023 and has held it in 11 quarters since. The position peaked at $227K in Q4 2023. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Vanguard Personalized Indexing Management held 22,805 shares of Nu Skin worth $120K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 3,898 Nu Skin shares in Q2 2026, an estimated $24.9K.
  • Nu Skin made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2025 holding.
  • Vanguard Personalized Indexing Management first reported a position in Nu Skin in Q4 2023 and has held it in 11 quarters since.
  • Vanguard Personalized Indexing Management's Nu Skin position peaked at $227K in Q4 2023.
  • 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.